Respiratory Decompensation in Preterm Infants Following Surgical Ligation or Device Closure of the Patent Ductus Arteriosus by Wheeler, Craig R.
 
Respiratory Decompensation in Preterm Infants Following Surgical Ligation or Device Closure 
of the Patent Ductus Arteriosus 
 
 
 
 
 
Craig R. Wheeler DHS(c), MSc. RRT-NPS 
 
Dissertation Committee Members 
Dr. Brian McCambley, DHSc, PA-C 
Committee Chairperson 
 
Dr. David Andrew Porter, DMSc, MSM, PA-C 
Committee Member 
 
Dr. Evelyn Prugar, PhD 
Committee Member 
 
 
 
 
 
 
DISSERTATION 
SUBMITTED IN PARTIAL FULFILMENT OF THE REQUIREMENTS  
FOR THE DEGREE OF DOCTOR OF HEALTH SCIENCES 
THE SCHOOL OF HEALTH SCIENCES 
UNIVERSITY OF BRIDGEPORT 
CONNECTICUT 
May 2021 
 
 
 
 
 
 
 
   
ii 
 
Respiratory Decompensation in Preterm Infants Following Surgical Ligation or Device Closure 
of the Patent Ductus Arteriosus 
 
 
 
 
 
 
 
 
 
 
 
 
© Copyright by Craig R. Wheeler 2021 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
iii 
 
 
   
iv 
 
Abstract 
 
Background: Temporal derangements in oxygenation and ventilation have been 
associated with surgical ligation and device closure of the ductus arteriosus. We sought to 
evaluate respiratory decompensation, defined as an increase of Respiratory Severity Score (RSS) 
>50% above pre-procedural value following surgical ligation (SL) or transcatheter PDA closure 
(TCPC). Methods: Premature infants <37 weeks gestational age who underwent invasive 
mechanical ventilation before and after PDA closure were included in the study. Included infants 
were grouped according to procedure type (SL or TCPC) and need for rescue high-frequency 
ventilation (HFV). RSS> 50% above baseline and HFV usage were measured at six intervals, 
from admission through 24-hours post-procedure. The Mann-Whitney U-test was used to assess 
differences in continuous variables and the chi-square and Fisher exact tests were utilized for 
categorical variables. The Holm-Sidak procedure was used to correct for multiple comparisons. 
Results: 110 infants, (n = 88) SL and (n = 22) TCPC were included for analysis. Twelve-hours 
post-procedure RSS> 50% was observed in 40% of SL compared to 3% of TCPC (p = .021) and 
rescue HFV at 24-hours was (42% vs. 5%, p = .004) for SL and TCPC respectively.  Rescue 
HFV was associated with SL (92% vs. 8%, p = .008), smaller gestational age (25 vs. 26 weeks, p 
= .003) and younger age at PDA closure (19 vs. 25 days, p = .003). Conclusion: In this study, we 
found that respiratory decompensation following closure of the PDA was associated with 
younger gestational age, younger age at PDA closure, surgical ligation, and elevated RSS values 
over the first 12 hours after closure. These results confirm prior data, but also suggest that an 
elevated RSS following PDA closure may be a useful non-invasive bedside tool to identify the 
respiratory phenotype of post ligation cardiac syndrome.   
Keywords: patent ductus arteriosus, prematurity, respiratory severity score, high-
frequency ventilation 
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Introduction  
 
The ductus arteriosus (DA) is a critical component of fetal circulation anatomically 
located between the pulmonary artery and aorta. In utero, the fetus receives oxygenated blood 
from the placenta, and blood is shunted away from the high resistance of the pulmonary vascular 
bed into the systemic circulation (Homma et al., 2016).  Following birth, the placental circulation 
is removed, pulmonary vascular resistance falls, and the pulmonary circulation becomes the 
source of oxygenated blood; hence, left-to-right shunting through the ductus is no longer 
required and can have a deleterious impact on the infant (Rios et al., 2018). Spontaneous closure 
of the DA occurs within 12 to 40-hours in the majority (>95%) of infants born >28 weeks of 
gestation (Jain et al., 2014; Rios et al., 2018). In contrast, persistent patent ductus arteriosus 
(PDA) is defined as a failure of the ductus to close within 72-hours postnatal age. Persistent PDA 
is observed in 70% of infants born <28 weeks and 80% for those born at 24-25 weeks gestation 
(Heuchan & Clyman, 2014; Rolland et al., 2015). 
PDA is the most commonly observed cardiovascular abnormality during the first year of 
life in preterm infants (Weisz & McNamara, 2014). A persistent PDA shunts blood away from 
the descending aorta and into the pulmonary artery, which may result in hemodynamic and 
cardiovascular abnormalities.  These abnormalities include increased pulmonary blood flow 
resulting in pulmonary over circulation with concurrent hypoperfusion of the gastrointestinal and 
cerebral circulations (Noori et al., 2009; Vali et al., 2019). Although no universal definition 
exists; PDA is considered hemodynamically significant (HsPDA) based upon the size, magnitude 
of shunt volume, and echocardiographic markers of systemic hypoperfusion and pulmonary over 
circulation (Lee, 2019). Further, HsPDA may result in heart failure, end-organ dysfunction, 
prolonged mechanical ventilation, supplemental oxygen dependency, bronchopulmonary 
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dysplasia (BPD), neurologic impairment, and death (Benitz et al., 2016; Clyman & Benitz, 2019; 
Noori et al., 2009; Rios et al., 2018; Vali et al., 2019; Weisz & McNamara, 2014). Treatment of 
PDA is variable and can be categorized into four broad options a) conservative, observe and wait 
for the PDA to close spontaneously; b) pharmacologic management; c) surgical ligation; and d) 
transcatheter device closure (Vali et al., 2019). Importantly, over 60 randomized control trials 
comparing PDA treatments have failed to establish causality, or demonstrate tangible reduction 
of adverse neonatal outcomes such as intraventricular hemorrhage (IVH), necrotizing 
enterocolitis (NEC), BPD, and death (El-Khuffash et al., 2019). As such, considerable 
controversy exists as to whether PDA or treatment thereof contribute directly to adverse neonatal 
outcomes; or if PDA is simply a common occurrence in this patient population.  
Characterization of Preterm Infants 
Preterm birth is a major public health concern, impacting roughly 15 million babies per 
year; of which  1 million die from complications related to preterm birth (WHO, 2018). Infants 
< 28 weeks gestation represent a formidable burden to the health care system and account for the 
majority of neonatal morbidity and mortality. The World Health Organization (WHO) defines 
birth prior to 28 weeks as extremely preterm, from 28 to 31 weeks as very preterm, from 32-36 
weeks as moderate-to-late preterm and > 37 weeks term (WHO, 2018). Additionally, preterm 
infants are conventionally classified by birthweight as described in Table 1.  
Table 1.  
 
Definition of Preterm Birthweights According to the World Health Organization 
 
Birthweight Category 
< 2500 grams Low birthweight (LBW) 
< 1500 grams Very low birthweight (VLBW) 
< 1000 grams Extremely low birthweight (ELBW) 
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Problems of Prematurity 
Over the past 30-years, advances in neonatal care including antenatal steroids, surfactant 
replacement therapy, and gentle ventilation strategies have improved the survival of extremely 
premature infants (Tracy & Berkelhamer, 2019). These interventions have reduced early deaths 
from respiratory failure with concomitantly increased morbidities as extremely premature infants 
22-25 weeks gestation; who once represented the fringe of viability, are now surviving longer. 
Consequently, extremely premature infants are more susceptible to developing late-onset sepsis, 
NEC, BPD, and retinopathy of prematurity (Stoll et al., 2015). Despite improved survival, 
morbidity including PDA remains high in the extremely preterm infant (Clyman & Benitz, 
2019). Current care includes early utilization of non-invasive respiratory support including 
continuous positive airway pressure or nasal intermittent positive pressure ventilation to reduce 
respiratory distress, ventilator-induced lung injury, and risk of BPD (Committee on et al., 2014; 
Jensen, 2019). Despite increased utilization of noninvasive respiratory support, invasive 
conventional mechanical ventilation continues to be the most common respiratory support 
modality for premature infants with RDS (Dargaville et al., 2016; Moya et al., 2019). Extremely 
premature infants are more likely to require both prolonged mechanical ventilation and definitive 
treatment of the PDA; a combination which is commonly associated with adverse neonatal 
outcomes, although the precise mechanisms and causal linkage remains to be established.  
Pulmonary Consequences of a Hemodynamically Significant PDA 
Preterm infants with a moderate-large HsPDA may be exposed to high-volume left-to-
right shunt for prolonged periods, resulting in pulmonary over circulation and edema formation; 
further reducing the low pulmonary compliance related to the RDS disease process (Appendix 
A). Progressive reductions in respiratory system compliance, coupled with worsened gas 
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exchange often necessitate escalation of mechanical ventilation support to maintain adequate 
oxygenation, ventilation, and pH (Giesinger et al., 2019). Therefore, infants with RDS and 
concurrent HsPDA are at high risk for the development of ventilator-induced lung injury and 
prolonged duration of mechanical ventilation. Indeed, the inability to liberate preterm infants 
from mechanical ventilation following the failure of pharmacologic interventions to close the 
PDA is the primary reason infants are referred for definitive closure of the PDA (Jhaveri et al., 
2010; Krishnappa et al., 2019).  
In theory, interventions to close the PDA should improve lung compliance and 
respiratory morbidities; however, there is a paucity of modern data in this area (Gerhardt & 
Bancalari, 1980; Lehenbauer et al., 2018; Naulty et al., 1978). Moreover, pulmonary function 
may be negatively impacted by PDA ligation surgery; as thoracotomy, dissection, and 
instrumentation of the lung and have been associated with complications including 
pneumothorax, bronchial obstruction, diaphragmatic paresis, and vocal cord paralysis (Vali et al., 
2019). Furthermore, in a subset of infants lung compliance remains unchanged or worsens 
following ligation and may require increased ventilator support (Heuchan et al., 2012; 
Szymankiewicz et al., 2004). Post-cardiac ligation syndrome (PCLS) complicates 28-45% of all 
PDA ligations and is characterized by symptoms including systemic hypotension with deficits in 
oxygenation and ventilation within 6-24 hours following the procedure (Clyman et al., 2014; 
Harting et al., 2008; Ulrich et al., 2018).  
The ability to predict which infants will demonstrate favorable improvements in lung 
compliance following definitive PDA closure is hampered by difficulties identifying the 
proportion of respiratory insufficiency that is related to HsPDA versus other risk factors 
associated with prematurity; mainly, evolving chronic lung disease and prolonged mechanical 
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ventilation (Krishnappa et al., 2019). While many investigators have described postoperative 
deficits in oxygenation and ventilation, few have comprehensively described the escalation phase 
of the ventilation strategy or identified an optimal point to transition to high-frequency 
ventilation (de Waal et al., 2009).  
High-Frequency Ventilation 
High-frequency ventilation (HFV) is an alternative form of mechanical ventilation that 
employs rapid breathing frequencies and delivers tidal volumes that are generally smaller than 
anatomic dead space (Lampland & Mammel, 2007). HFV is often used as a lung-protective 
rescue approach when gas exchange deteriorates and infants can no longer be safely supported 
on conventional mechanical ventilation (Wheeler, Smallwood, O'Donnell, Gagner, & Sola-
Visner, 2017). Notably, randomized studies comparing the use of high-frequency oscillatory 
ventilation (HFOV) and high-frequency jet ventilation (HFJV) to conventional mechanical 
ventilation have not demonstrated significant benefits in neonatal outcomes for elective or rescue 
usage (Cools et al., 2015; Rojas-Reyes & Orrego-Rojas, 2015). Additionally, these trials were 
conducted decades ago and excluded extremely premature infants (e.g. 22-25 weeks). Despite 
the lack of conclusive evidence, HFV is a standard of care for premature infants with 28% to 
62% of infants between 22-28 weeks gestation receiving some type of HFV during their stay in 
neonatal intensive care (Patel et al., 2015; Stoll et al., 2015).  However, risk factors associated 
with conventional mechanical ventilation failure and the subsequent need for rescue HFV have 
not been adequately described in the setting of PDA. Currently, there are no predictive tools to 
aid bedside clinicians in deciding if and when HFV should be initiated. Therefore, it is desirable 
to clearly define the conventional ventilation strategy in relation to the development of 
respiratory decompensation following interventions to close the PDA.  
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Metrics of the Severity of Respiratory Illness in Preterm Infants 
Historically, the oxygen index: (OI = mean airway pressure x FIO2 x 100 / PaO2) was 
utilized to assess the severity of respiratory illness, direct interventions, and evaluate response to 
therapies such as surfactant, HFV and inhaled nitric oxide (Golombek & Young, 2010; Stewart et 
al., 1996; Willson et al., 2005).  In contemporary practice, umbilical lines are time-limited and the 
routine placement of peripheral arterial lines in premature infants is infrequent due to small patient 
size or concerns of infection, thrombosis, iatrogenic anemia, and ischemia (de Brito et al., 2010; 
Deindl et al., 2018; Shahid et al., 2014). The lack of arterial access precludes infants from the 
routine calculation of OI and subsequent risk stratification.  
Respiratory severity score (RSS = mean airway pressure x FiO2) is a validated noninvasive 
surrogate for OI, used to assess the severity of respiratory failure in premature infants undergoing 
mechanical ventilation (Malkar et al., 2015). A low RSS denotes less respiratory support, 1.6 has 
been associated with successful extubation (Mhanna et al., 2017), 3.5 represents more severe lung 
disease (Ballard et al., 2006) and RSS ≥ 6 on day of life 30 has been associated with increased 
mortality and prolonged duration of mechanical ventilation (Malkar et al., 2015).  
Statement of the Problem 
PDA is a frequent complication in preterm infants with RDS and is inversely proportional 
to gestational age. While the optimal timing and treatment of PDA remains controversial; the 
inability to wean from mechanical ventilation is the primary reason infants are referred for 
surgical or catheter-based interventions to close the PDA. Respiratory decompensation following 
interventions to close the PDA is a relatively common occurrence in the perioperative 
management of these infants. The ability to predict escalations in mechanical ventilator settings 
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is desirable and may allow for timely individualization of the ventilation strategy and 
improvement in pulmonary outcomes for this fragile patient population.   
Purpose of the Research 
The purpose of the present study is to: a) describe risk factors associated with failure of 
conventional mechanical ventilation in premature infants following surgical ligation (SL) or 
transcatheter PDA closure (TCPC); b) describe phenotypes of preterm infants that are at elevated 
risk for the development of respiratory decompensation following SL or TCPC and c) describe 
differences in outcomes, such as requirement for rescue with HFV, need for vasoactive 
medications, duration of mechanical ventilation, length of stay and morbidity between subjects 
who had SL and those who underwent TCPC. 
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Review of the Literature 
 
Overview of Fetal Circulation and the Physiology of Transition 
 
The transition from intrauterine to extrauterine life is characterized by a complex 
sequence of physiologic adaptations prior to the establishment of post-natal circulation 
(Deshpande et al., 2018). Fetal lungs do not participate in gas exchange; therefore, the fetus is 
reliant upon the mother’s placenta to provide oxygen and nourishment. Fetal circulation involves 
a series of three shunts: a) ductus venosus; b) foramen ovale; and c) the ductus arteriosus 
(Appendix B).   
Antenatally, oxygenated blood and nutrients enter the fetal circulation; flowing from the 
placenta via the umbilical vein to the inferior vena cava and transiting the ductus venosus to the 
right atrium (RA). The oxygenated blood from the ductus venosus mixes with the deoxygenated 
venous blood returning to the RA. Approximately two-thirds of this admixture is shunted from 
the RA through a hole in the septum between the right and left atrium; referred to as the patent 
foramen ovale (PFO). As such, 90% of the blood entering the PA bypasses pulmonary 
circulation via the patent ductus arteriosus, with the remaining 10% entering the pulmonary 
vascular bed (Homma et al., 2016). Further, the hypoxemic fetal environment promotes the 
production of endogenous prostaglandin E2 (PGE2) and prostaglandin I2 (PGI2); which maintain 
ductal patency (Rios et al., 2018). 
From the left atrium (LA), oxygenated blood enters the left ventricle (LV) before being 
pumped into the aorta and systemic circulation. The remaining one-third of blood in the RA is 
directed to the right ventricle (RV) and subsequently ejected into the pulmonary artery (PA). 
Importantly, fetal life is characterized by non-participation of the lungs and dependence upon the 
placenta for gas exchange.  In utero, fetal lungs are filled with fluid and have a high pulmonary 
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vascular resistance (PVR). Two primary factors contribute to high fetal PVR; hypoxic 
vasoconstriction secondary to low oxygen concentrations in pulmonary blood flow and direct 
compression of the pulmonary vessels by the mechanism of low lung volumes.   
Ductal Patency and Mechanisms of Closure 
The onset of ventilation is considered responsible for initiating the physiologic transition 
from fetal circulation to postnatal circulation (Deshpande et al., 2018). Following the initial 
series of breaths and the establishment of functional residual capacity, alveolar oxygen content 
dramatically increases; resulting in a rapid reduction of PVR. The sudden reduction in PVR 
promotes increased pulmonary blood flow. Moreover, clamping of the umbilical cord and 
removal of the placenta from the systemic circulation marks a rapid increase in SVR with a 
concurrent reduction in right-heart preload.  
The combination of reduced PVR and increased SVR generally leads to a progressive 
reversal of blood flow across the PDA, from entirely right-to-left to predominately left-to-right 
(Rios et al., 2018). At this stage, the PDA is exposed to high systemic arterial oxygen 
concentration with concurrent reductions in bradykinin production and circulating prostaglandin 
levels, which are thought to induce vasoconstriction and functional closure of the PDA 
(Deshpande et al., 2018). In a prospective study, Jain et al. (2014) performed serial 
echocardiograms during the first 48-hours of life and demonstrated that 96% of term infants had 
no transductal flow by 40-hours of age; suggestive of functional PDA closure. In contrast, 70% 
of preterm infants < 28 weeks and 80% of those born at 24-25 weeks gestation failed to have 
spontaneous closure of the DA within the first 10-days of life (Koch et al., 2006; Madan et al., 
2009). Further, Semberova and colleagues (2017) reported that among 280 VLBW infants who 
underwent conservative management for PDA, 85% had spontaneous closure before hospital 
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discharge.  Therefore, without early treatment to close the DA, a subset of preterm infants will be 
exposed to systemic left-to-right shunting across the PDA for a period of time, with most PDAs 
closing spontaneously by 44 weeks postmenstrual age (Slaughter et al., 2019). While the clinical 
significance and role of this exposure has not been fully elucidated; it is important to consider 
PDA in context with phases of lung development. 
PDA: In Context with Phases of Lung Development 
Lung development occurs in four overlapping phases of gestation: a) embryonic period 
(0-6 weeks); b) pseudoglandular (6-16 weeks); c) canalicular (16-24 weeks) and d) saccular (24-
40 weeks). The expansion of pulmonary circulation mirrors each respective lung development 
stage with capillary and vascular branching, supplying perfusion to the rapidly expanding 
pulmonary tree. Lung development begins approximately four-weeks following conception with 
the formation of large airways including the trachea, mainstem bronchi, and initial segments of 
smaller conducting airways (Schittny, 2017).  
The early pseudoglandular phase is characterized by the completion of 20 generations of 
smaller conducting airways and the first few generations of alveolar ducts (Smith et al., 2010). 
The canalicular phase represents the development of the pulmonary parenchyma, multiplication 
of capillaries, and formation of the capillary network around airspaces. Notably, at around 20 
weeks of gestation type II alveolar cells appear and are responsible for the synthesis, storage, and 
secretion of surfactant. Moreover, the two primary developments during the canalicular stage 
include formation of the air-blood barrier and the beginning of surfactant production (Schittny, 
2017). During the saccular stage, the terminal airways grow in length and diameter forming 
clusters of distal airspaces. The resulting clusters or saccules are defined as the alveolar ducts 
and alveolar sacs, however, true alveoli do not begin to form until 32-36 weeks (Smith et al., 
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2010). The final stage of lung development, alveolarization, is characterized by the formation of 
mature true alveoli.  
Alveoli are thin-walled sacs that enable gas exchange across the capillary membrane; in 
which, carbon dioxide is removed from the blood, and oxygen is added with each successive 
breath. The alveoli are comprised of thin, flat, type I epithelial cells which cover 90% of the 
inner surface, and type II  epithelial cells which occupy the remaining 10% (Evans et al., 1973). 
Alveolarization is the final stage of lung development, which represents the formation of fully 
functional alveoli and occurs between 36 weeks to 2-years postnatal age (Langston et al., 1984). 
Alveolarization is thought to be mostly completed between 18-24 months of age (Burri, 2006).  
Surfactant 
  The pulmonary surfactant system is a crucial component to maintaining alveolar 
expansion and adequate surface area for gas exchange. Surfactant is a lipid that coats the inner 
surface of the alveoli and reduces surface tension; thereby promoting alveolar stability and 
preventing alveolar collapse (Orgeig et al., 2015). While the type II epithelial cells are present at 
20 weeks gestational age, the quality and production of surfactant is insufficient until around 30 
weeks gestation (Smith et al., 2010). It is important to highlight that both lung development and 
surfactant production are incomplete in extremely preterm infants; as their genesis temporally 
coincides with the pseudoglandular or canalicular periods. As such, these infants have 
underdeveloped lungs and surfactant deficiency, with most requiring exogenous surfactant 
replacement and positive-pressure ventilation.  
Respiratory distress syndrome 
  Respiratory distress syndrome (RDS) is the primary cause of respiratory failure in 
premature infants, resulting from immature lung development and surfactant deficiency (Stoll et 
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al., 2015). Historically, surfactant was routinely administered to preterm infants via an 
endotracheal tube in combination with mechanical ventilation. However, mounting evidence 
from multicenter randomized control trials and subsequent meta-analyses indicate that nasal 
continuous positive airway pressure (CPAP) is an effective alternative to intubation and 
prophylactic surfactant administration (Bahadue & Soll, 2012; Fischer & Buhrer, 2013; Rojas-
Reyes et al., 2012). Based upon these data, the American Academy of Pediatrics recommends 
CPAP utilization immediately after birth for spontaneously breathing infants, with selective 
surfactant replacement being reserved for infants who subsequently require intubation and 
mechanical ventilation (Committee on et al., 2014). Therefore, current treatment includes early 
utilization of CPAP to reduce respiratory distress, ventilator-induced lung injury, and risk of 
BPD (Committee on et al., 2014; Jensen, 2019).  
Despite increased utilization of non-invasive respiratory support, approximately 50% of 
infants < 28 weeks GA subsequently require intubation and mechanical ventilation, with risk 
increasing inversely to GA. Moreover, 70% of infants undergo invasive mechanical ventilation 
preceding the initiation of CPAP in the delivery room (Dargaville et al., 2016; Moya et al., 
2019). Therefore, the majority of extremely premature infants require invasive mechanical 
ventilation. Although mechanical ventilation is a life-saving intervention for preterm infants, it 
has been associated with increased mortality and development of morbidities including BPD, 
retinopathy of prematurity, and neurodevelopmental impairment (Chawla et al., 2017). 
Considering the prevalence of both RDS and PDA are inversely proportional to gestational age, 
the resultant risk factors are similar to considerable overlap in morbidities. 
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Management of Mechanical Ventilation in Preterm Infants 
The role of mechanical ventilation is to safely support effective gas exchange while 
minimizing the risk of ventilator-induced lung injury. Preterm infants are most commonly 
ventilated using pressure-control or volume-targeted modes of ventilation. In pressure-controlled 
modes, tidal volume (VT) is variable and peak inspiratory pressure (PIP) is constant; and in 
volume-targeted ventilation, VT is set and PIP is variable; both are affected by changes in lung 
compliance and resistance. Despite the choice in mode, the general aims of the ventilation 
strategy are to a) prevent alveolar over-distention or volutrauma by controlling VT  in the 4-6 
mL/kg range and limiting PIP < 25 cm H2O; b) titrate positive end-expiratory pressure (PEEP) to 
reduce the repetitive closing and reopening of alveolar lung units or atelectrauma via recruitment 
and maintenance of end-expiratory lung volume or functional residual capacity; c) minimize 
swings in the partial pressure of arterial carbon dioxide (PaCO2) and blood pH levels; and d) 
reduce exposure to a high fraction of inspired oxygen (Klingenberg et al., 2017).  
Variability in patient size, lung maturity, available equipment, presence of endotracheal 
tube cuff leak, and the heterogeneous range of acute and chronic diagnoses make the 
development of a single “ventilator strategy” difficult.  Therefore, the mode of ventilation and 
combination of settings are individualized according to patient characteristics, with considerable 
variation based upon the underlying condition and institutional preference.  
 Mechanical ventilation strategies can influence blood flow through the PDA. A review of 
how mechanical ventilation is used in the perioperative management of single-ventricle 
physiology, such as hypoplastic left heart syndrome (HLHS) illustrates this relationship. Unlike a 
structurally normal heart where blood flow is supplied in series and managed by two ventricles 
(right and left), the infant with HLHS is dependent upon a single right ventricle. In single-
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ventricle physiology, cardiac output is supplied in parallel with blood flow being divided 
between both pulmonary and systemic circuits (Rossano & Chang, 2006). These infants are 
reliant on the PDA to provide systemic perfusion (right-to-left shunt). The distribution of 
pulmonary blood flow (Qp) and systemic blood flow (Qs) is directly influenced by resistance in 
the pulmonary and systemic circulation; which are considered to be balanced when the Qp: Qs 
ratio equals 1:1 (Barnea et al., 1994). The gradual reduction in PVR after the first few days of 
life leads to an imbalance or over circulation of the pulmonary circuit with concomitant 
hypoperfusion of the systemic circulation; increased Qp and decreased Qs. Mechanical 
ventilation strategies to increase PVR include a) low fraction of inspired oxygen (FiO2  0.21-
0.25); b) permissive hypercapnia; and c) increased mean airway pressure. Collectively, these 
strategies can be utilized for infants with HsPDA to increase PVR to reduce DA shunt volume. 
 The pulmonary vasculature is responsive to both hypoxia and acidosis; both of which can 
be manipulated during invasive mechanical ventilation to induce vasoconstriction and increase 
PVR. Permissive hypercapnia refers to purposely allowing the partial pressure of carbon dioxide 
(PCO2) in the blood to exceed normal physiologic limits (e.g. > 45 mm Hg). Carbon dioxide 
exerts opposing effects on the pulmonary and systemic vasculature; with hypercapnia resulting in 
pulmonary vasoconstriction and systemic vasodilation (Smith et al., 2018). The proposed 
benefits of hypercapnia in premature infants is to minimize the risks of mechanical ventilation to 
reduce lung injury and neurologic damage. However, a meta-analysis of 4 randomized control 
trials failed to demonstrate efficacy in reducing BPD, ROP, NEC, IVH, or neurodevelopmental 
outcomes of extremely low birth weight infants (Ma & Ye, 2016). Nevertheless, permissive 
hypercapnia is commonly utilized in the management of preterm infants undergoing mechanical 
ventilation. While the physiologic basis of utilizing hypercapnia to induce pulmonary 
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vasoconstriction is sound, there have been no studies to date investigating the impact of 
permissive hypercapnia on HsPDA (Smith et al., 2018). 
Mean airway pressure (?̅?aw) is calculated as: ?̅?aw = (PIP – PEEP) x TI/Ttotal) + PEEP; 
where TI is inspiratory time and Ttotal is total respiratory cycle time (Hess, 2014). Small 
observational studies have evaluated the efficacy of lung recruitment using higher levels of 
PEEP or mean airway pressure on pulmonary, systemic, and ductal blood flow (de Waal et al., 
2009; de Waal et al., 2007). Fajardo et al, compared PEEP levels of 5 and 8 cmH2O in preterm 
infants with PDA and found that mild reductions in left-to-right shunt through the DA was 
associated with PEEP of 8 cmH2O and without impairment of cerebral oxygenation and 
perfusion (Fajardo et al., 2014)  In contrast, de Waal and colleagues prospectively studied the 
effect of lung recruitment in a cohort of mostly premature infants receiving HFOV and found no 
significant differences in ductal shunting when comparing a ?̅?aw of 8 cmH2O to 20 cmH2O (de 
Waal et al., 2009). ?̅?aw is a frequently monitored parameter in infants undergoing mechanical 
ventilation which can be used to characterize the level of ventilator support and has been 
factored into several indices for stratification of respiratory illness severity; including the OI, 
RSS, and oxygen saturation index. For example, infants who are ready to be liberated from 
mechanical ventilation typically have ?̅?aw < 10 cm H2O; whereas, infants with moderate-severe 
respiratory failure ?̅?aw often exceed 15 cm H2O.  
Treatment of PDA 
Despite decades of research, including over 65 randomized control trials, the optimal 
management strategy for PDA remains highly controversial; as none of the current treatment 
strategies have demonstrated tangible improvements in the outcomes of premature infants with 
PDA (Smith & El-Khuffash, 2020). This lack of consensus is underscored in a recent survey that 
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compared the management strategies for PDA in premature infants in the United States. 
Sathanandam et al. (2019) found that 80% of cardiologists believed that PDA closure impacts 
preterm morbidity and mortality as compared to 54% of neonatologists (p <.001). Neonatologists 
preferred conservative management, whereas cardiologists favored interventions to close the 
PDA (77% vs. 95%, p < .001). While the timing and method of closure was variable between 
groups, over 60% of both groups agreed that HsPDA in preterm infants warranted treatment. 
Hemodynamically Significant Patent Ductus Arteriosus 
The term “hemodynamically significant PDA” or HsPDA is frequently used to 
differentiate between a small PDA which may have little impact on circulation, from a 
symptomatic (high shunt volume) PDA which is likely to result in systemic hypotension. 
Therefore, PDA can be conceptualized on a continuum ranging from supportive to pathologic, 
taken in context with gestational age. In infants with complex congenital heart disease, 
maintaining ductal patency is imperative to supplying either pulmonary (e.g. pulmonary atresia, 
Ebstein’s anomaly) or systemic circulations (e.g. coarctation of the aorta, hypoplastic left heart 
syndrome) to prevent congestive heart failure until surgical repair can be performed. 
Additionally, maintaining ductal patency in infants with acute pulmonary hypertension can also 
be supportive, as the PDA permits right-to-left flow in the setting of systemic RV pressures and 
RV dysfunction.  
In preterm infants without congenital heart disease or pulmonary hypertension, the PDA 
evaluation can be subdivided into either physiologic or pathologic manifestations. For infants 
with physiologic PDA, there is minimal impact on cardiovascular stability; whereas, a pathologic 
PDA contributes directly to hemodynamic instability (Rios et al., 2018). Therefore, optimal 
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management of PDA must be individualized based on whether the PDA is physiologic or 
pathologic.  
 Classic clinical symptoms of the HsPDA include tachycardia, cardiac murmur, 
hyperactive precordium, bounding pulses, and widened pulse pressure. Moreover, HsPDA may 
be suspected based on radiographic observation of increased pulmonary congestion and 
cardiomegaly in context with the need for escalation of mechanical ventilation settings or 
difficulty weaning from mechanical ventilation (Su et al., 2020). However, these findings lack 
specificity and cannot accurately diagnose if the PDA is pathologic. Therefore, the widespread 
use of serial transthoracic echocardiography (TTE) has provided significant insight into the 
clinical evaluation of ductal shunting and quantification of HsPDA.  
 The assessment of HsPDA is multifactorial and represents a complex interaction between 
several intrinsic and extrinsic factors (Appendix C). Unfortunately, there is no universal 
definition of HsPDA to guide clinicians in determining whether the DA requires intervention or 
will close spontaneously. Many trials have utilized arbitrary cut-offs based on PDA size, which 
may not fully account for the underlying pathologic consequences or resultant short and long-
term outcomes related to HsPDA (El-Khuffash et al., 2019). According to El-Khuffash, Levy, 
Gorenflo & Frantz (2019) several factors including a) the influence of PDA shunt volume on 
pulmonary and systemic circulation; b) myocardial function; and c) perinatal characteristics 
which may modify or exacerbate pathologic consequences of the shunt must be considered. 
Indeed, assessment of shunt volume rather than measurements of PDA size afford a more 
complete appraisal of the hemodynamic impact of the PDA.  
 Quantification of blood flow in the cardiovascular system is derived from Ohm’s Law as 
applied to hydraulic systems, where blood flow (Q) is equal to the pressure gradient (P) divided 
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by vascular resistance (RV) as denoted by the equation: Q = 
P
Rv
  (Gerrah et al., 2017). Velocity (u) 
is a clinically relevant parameter in the assessment of cardiovascular performance. Increased 
velocity is often associated with pathology; with a PDA this can be appreciated during 
auscultation as a cardiac murmur representing flow turbulence through the PDA. Blood flow 
across the PDA is governed by Poiseuille’s Law which describes the relationship between 
transductal pressure gradients, diameter, length, and viscosity (Appendix D). Notably, vessel 
diameter (d4) corresponds to a fourth-order relationship with flow; where small changes in vessel 
size have a dominant impact on flow dynamics. The Bernoulli Principle (Appendix D) expresses 
the relationship between flow, velocity, and pressure. During peak systole, blood flow from the 
aorta (high-pressure) transits the PDA (smaller diameter) before entering the pulmonary artery 
(larger diameter, lower pressure). As such, the pressure drop across the PDA results in 
conversion of high-pressure low-velocity flow to low-pressure high-velocity flow; resulting in a 
pressure gradient between the aorta and pulmonary artery (Gerrah et al., 2017). Importantly, the 
diameter, length, blood viscosity, transductal pressure gradients and flow across the PDA all 
change considerably in the first few days of life (de Freitas Martins et al., 2018). Therefore, 
ductal blood flow is dependent upon downstream resistance and other factors such as a) PDA 
size in diameter; b) the pressure difference between the aorta and pulmonary artery; c) runoff 
during diastole; d) turbulence and e) the Venturi effect with smaller restrictive PDAs; increased 
velocity with subsequent decrease in pressure.  Clinically, these principles are incorporated into 
patient assessment using Doppler echocardiography to quantify pressure gradients, shunt 
volume, and hemodynamic significance.  
Assessment of echocardiographic markers of PDA pathology and hemodynamic 
significance has become the standard of care in neonatal intensive care units (El-Khuffash & 
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McNamara, 2017). The intricate relationship between HsPDA; mainly magnitude and duration of 
exposure to ductal shunt has been associated with reduced lung compliance and may potentially 
expedite the inflammatory process leading to chronic lung disease (Clyman et al., 2020; Schena 
et al., 2015).  Moreover, the runoff or diastolic “steal” phenomenon occurs when blood moves 
from vessels of high-pressure such as the aorta to those with lower pressures including the 
pulmonary circuit. This concept is exemplified by flow reversal during diastole in the descending 
aorta, which is commonly observed via TTE in infants with HsPDA.  
Therefore, it is desirable to identify HsPDA early to determine which infants can be 
conservatively managed from high-risk infants that require prompt interventional management 
(e.g. < 26 weeks). El-Khuffash and colleagues (2015) comprehensively examined 
echocardiographic and physiologic characteristics of infants < 29 weeks gestation using an 
observational multicenter prospective design. The cohort was divided based upon the binary 
outcome; presence or absence of chronic lung disease (CLD). Univariate and multivariable 
logistic regression analyses were performed to identify independent predictors of CLD and death 
before discharge. These authors identified gestational age, PDA diameter, maximum flow 
velocity, LV output (a marker of shunt volume and over circulation), and LV a’ wave (a measure 
of LV diastolic function) on day of life two as independent predictors of CLD and death. From 
these data, a clinical scoring system was derived, ranging from 0 (low-risk) to 13 (high-risk). The 
model demonstrated excellent predictive capability with an area under the receiver operating 
characteristic curve (AUC) of 0.92 (95% CI 0.86-0.97, p <0.001). Infants who ultimately 
developed chronic lung disease or death had higher scores with a cut-off score of 5 being 
predictive of CLD or death; sensitivity and specificity of 92% and 87% respectively. It is 
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important to underscore that the mechanical ventilation strategy also has significant impact on 
the development of CLD. 
PDA Treatment Modalities 
The need for PDA treatment continues to be a contentious topic given the high rate of 
spontaneous closure, evidence of moderate efficacy for pharmacologic treatment, and concerns 
that iatrogenic effects related to treatment may outweigh benefits. Historically, all PDAs were 
treated early with either pharmacologic or surgical intervention without assessment of 
hemodynamic impact. Over time, mounting evidence of adverse neonatal outcomes related to 
PDA management has led to skepticism about universal treatment; as this approach 
unnecessarily exposes some infants to potential harm (Lee, 2019).  Therefore, trends in 
management have become more conservative, with decision to treat being deferred and re-
evaluated based on the risks/benefit profile of each individual patient. Treatment modalities for 
PDA can be separated into four options: 1) Conservative management; 2) Pharmacologic 
therapy; 3) SL and 4) TCPC. The relative advantages and disadvantages of each modality is 
summarized in (Table 2.). 
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Table 2.   
A Comparison of Treatment Options for HsPDA 
Pharmacologic SL TCPC 
Advantages: 
• Non-invasive 
• Efficacy 50-70% 
• May take days to be effective 
 
Advantages: 
• Efficacy 100% 
• Immediate and definitive 
closure 
Advantages: 
• Minimally-Invasive 
• Efficacy 100% 
• Immediate and definitive 
closure 
 
Disadvantages: 
• Renal impairment, oliguria, 
proteinuria, hyperkalemia 
• Reduced effectiveness for 
ELBW infants 
• White-matter damage 
• Impaired cerebral perfusion 
• NEC, SIP 
• Platelet dysfunction 
 
Disadvantages: 
• Post-Cardiac Ligation 
Syndrome (30%) 
• Vocal cord dysfunction 
(30%) 
• Impaired 
neurodevelopmental 
outcomes 
• Surgical complicationsa 
• Cardiorespiratory failure 
Disadvantages: 
• Vascular access complications 
(1%) 
• LPA stenosis (1%) 
• AA stenosis (1%) 
• Device embolization (1%) 
• TV damage or regurgitation 
• Exposure to radiation and 
contrast 
• Hypothermia 
 
Note. ELBW = extremely low birthweight infant, NEC = necrotizing enterocolitis, SIP = spontaneous intestinal 
perforation, LPA = left pulmonary artery, AA= aortic arch, TV = tricuspid valve. *Reprinted with permission from 
“PDA Closure in ELBW: If, When, and How to do it” by S. Whiting, and S. Sathanandam, 2019, Update on Critical 
Issues on Infant and Neonatal Care, p. 5. Copyright 2019 by IntechOpen. 
 
aSurgical complications include chylothorax, pneumothorax, diaphragmatic paralysis, vocal cord paresis, bleeding 
and scoliosis.  
 
Conservative Treatment 
 Conservative treatment is contingent upon the possibility of the DA closing naturally 
without treatment. Conservative treatment is an umbrella term for the combination of several 
non-pharmacologic strategies aimed at decreasing the magnitude of left-to-right shunt via the 
PDA. As previously mentioned, mechanical ventilation strategies using higher levels of PEEP, 
permissive hypercapnia, and lower FiO2 are often utilized to increase PVR with the goal of 
reducing shunt volume. Additionally, fluid restriction (≤ 130 mL/kg/day) to minimize left-heart 
loading, targeting higher hematocrit levels 35-40% (to increase viscosity) and diuresis may be 
considered to mitigate pulmonary edema formation (Smith et al., 2018).  
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Pharmacologic treatment 
  Pharmacotherapeutic agents, mainly non-steroidal anti-inflammatory drugs (NSAIDS) 
such as indomethacin and ibuprofen or non-aspirin pain reliever (acetaminophen) have been used 
as first-line therapies to close PDA. The administration of NSAIDS or acetaminophen inhibits 
cyclo-oxygenase enzyme, resulting in downregulation of PGE2, a potent vasodilator that 
potentiates ductal patency. Several treatment strategies have been investigated including a) 
prophylaxis, where all infants are treated early within the first few hours of life; b) early 
symptomatic, where infants with HsPDA receive NSAIDS between 2-5 days of life; and c) late-
symptomatic, where infants with HsPDA receive treatment between 10-14 days of life (Heuchan 
& Clyman, 2014).  Despite over 60 RCTs focusing solely on pharmacologic management, the 
efficacy, timing, optimal dosing, and safety profiles of these drugs remain incomplete (Marconi 
et al., 2019). Recent meta-analysis of these studies suggests failure rates of 0.24, 95% CI [0.20, 
0.29] for indomethacin; 0.18 [0.14, 0.22] for ibuprofen; 0.19 [0.09, 0.30] for acetaminophen; and 
0.59 [0.48, 0.69] for control (no treatment), respectively (Marconi et al., 2019).  
Notably, the survival rate of infants born at 23 weeks gestation has improved due to 
advances in neonatal medicine. Dani and colleagues (2019) performed a multicenter 
retrospective analysis including infants with HsPDA born between 23-28 weeks gestation. These 
authors found that HsPDA occurred in 70% of infants born at 23-24 weeks gestation vs. 59% of 
infants born between 25-28 weeks (Dani et al., 2019). Moreover, failure of the first treatment 
cycle and subsequent need for SL were significantly higher among the 23-24 week group when 
compared to infants born between 25-28 weeks gestational age (69% vs. 40%; p <.001) and 
(19% vs. 10%; p = .011), respectively.  
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Surgical Ligation  
Surgical ligation of the PDA is performed when pharmacologic treatment is not 
successful or contraindicated in the setting of NEC, decreased urine output, or elevated risk for 
bleeding (Lee, 2019). SL is achieved by placing a clip or ligature around the PDA, resulting in 
immediate closure (Appendix E). The invasive nature of the procedure itself may negatively alter 
pulmonary function as it requires thoracotomy, retraction of the ribs, dissection, and 
instrumentation of the lung to provide access to the DA. Moreover, SL is associated with 
complications including pneumothorax, bronchial obstruction, diaphragmatic paresis, vocal cord 
paralysis, and scoliosis (Vali et al., 2019). Overall, mortality following SL is low; however, 
between 28-45% of all PDA ligations are complicated by post-cardiac ligation syndrome 
(Giesinger et al., 2019; Harting et al., 2008; Ulrich et al., 2018). 
 Post-cardiac ligation syndrome (PCLS) is a phenomenon characterized by systemic 
hypotension and deficits in ventilation and/or oxygenation during the 6-24 hour period following 
SL (Giesinger et al., 2019). PLCS or low cardiac output syndrome occurs secondary to sudden, 
drastic changes of the loading condition on the left side of the heart following the abrupt closure 
of the PDA (McNamara et al., 2010; Nealon et al., 2019; Noori et al., 2007). The mechanisms of 
PLCS are complex and incorporate respiratory decompensation, myocardial dysfunction, and 
vascular tone dysregulation (Noori & Kumar, 2017). PLCS has been defined as a composite 
outcome of the need for inotropic agents and oxygenation failure and/or ventilation failure in the 
absence of any other surgery-related etiology, such as hypovolemia, sepsis, pneumothorax, and 
chylothorax (Jain et al., 2012; Ulrich et al., 2018). A schematic of factors contributing to PCLS 
is displayed in (Appendix E). 
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Transcatheter PDA Closure 
 The recognition of potential risks of SL has led to the exploration of an alternative 
minimally invasive, approaches to close the PDA (Backes et al., 2019). Catheter‐based closure of 
the PDA is among the safest of interventional cardiac procedures and is considered the procedure 
of choice for PDA closure in infants > 5 kg (Backes et al., 2016; Lam et al., 2015). In recent 
years, devices suitable to “plug” the PDA of premature infants (including extremely low birth 
weight, <1000 g) have become available and several trials have demonstrated successful and safe 
TCPC in this population (Backes et al., 2017). The Amplatzer Piccolo Occluder Device is one 
of these devices and is a percutaneous, transcatheter occlusion device intended for the 
nonsurgical closure of a PDA. The device was approved for infants > 700 grams by the Food and 
Drug Administration in January 2019 and the first Piccolo device was placed at Boston 
Children’s Hospital in May 2019.  
The Amplatzer Piccolo Occluder is a self-expanding, nitinol mesh occlusion device for 
use in infants to close the PDA. Device configuration consists of a central waist with two 
retention discs and is configured specifically for PDA morphologies encountered in ELBW 
infants. In addition to the device’s small size and adjustable profile, the approach for 
implantation of this device in ELBW infants differs from larger infants (e.g. > 5 kg). In larger 
infants, the combination of femoral arterial and venous access is performed in the catheterization 
laboratory to guide and adjust device placement. In infants < 2 kg, arterial access is generally 
avoided due to the potential for vascular insufficiency and limb loss (Alexander et al., 2016; 
Backes et al., 2016). Therefore, to minimize the risk of vascular damage, an alternate approach is 
employed in smaller infants using venous access with a combination of echocardiographic and 
fluoroscopic guidance to position and deploy the device (Appendix F).  
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Respiratory Decompensation Review 
Several investigators have compared SL to TCPC and found improvement in respiratory 
morbidity including shorter duration of ventilation, less severe respiratory compromise, more 
rapid return to baseline respiratory status, and shorter length of stay (Hazeem et al., 2013; Regan 
et al., 2020; Rodriguez-Ogando et al., 2018; Sathanandam et al., 2018; Balduf, et al., 2019) and 
lower incidence of PCLS (Serrano et al., 2020). These findings contribute to the emerging body 
of literature suggesting that occluding PDA via TCPC may result in less postprocedural 
cardiorespiratory compromise and improvement in short-term outcomes when compared with SL 
(Appendix G). 
Except for Regan (2020) the above investigations included single-center, retrospective 
designs with small sample sizes. First, the nonrandomized nature of these investigations was 
reliant on the accuracy of the medical record and may have introduced bias (selection, historical, 
measurement) or unmeasured covariates. To address the concerns of analyzing retrospective 
data, two of the largest studies used propensity score matching to balance groups based on 
gestational age and weight; both of which are known confounding variables in preterm infants 
(Regan et al., 2020; Sathanandam et al., 2018; Balduf, et al., 2019).  Propensity score matching 
aims to balance treatment groups concerning baseline covariates to reduce selection bias and 
other potential confounding variables; hence, allowing for a more even comparison of treatment 
effect (Staffa & Zurakowski, 2018).  
Second, the study by Serrano et al. (2020) suggests extremely preterm infants are less 
likely to develop PCLS following TCPC when compared with their SLC counterparts (20 % vs. 
0 %, p = .016). These findings must be interpreted with caution as no a priori power analysis was 
performed and hemodynamic support was considered a binary outcome representing the receipt 
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of hydrocortisone, dopamine, and epinephrine. Moreover, the decision to initiate hemodynamic 
support was not protocolized and at the discretion of the attending physician. As such, the 
incidence of post-ligation cardiac syndrome following TCPC remains largely unknown and 
warrants further investigation. 
Third, the timing of intervention may have an important impact on the development of 
pulmonary comorbidities. Sathanandam and colleagues (2018) used Kaplan-Meier estimates to 
compare the decline of RSS over time until freedom from RSS  1 (minimal ventilator support) 
occurred. These authors found that late repair (> 8 weeks of age) and elevated pulmonary 
pressure ( 75% of systolic blood pressure) were independently associated with prolonged (>30 
days) elevation of RSS  1; OR = 5.4, 95% CI [2.2, 9.4], P < 0.01 and OR = 2.86, 95% CI [1.5, 
4.2], p < 0.05, respectfully.  These findings suggest that earlier closure may confer benefit by 
avoidance of higher pulmonary artery pressures resultant from prolonged high-volume shunt and 
progressive development of pulmonary vascular disease. Moreover, early TCPC resulted in a 3-
fold reduction in RSS  1, which equates to a shorter duration of mechanical ventilation.  
Further, these findings are in line with other studies that found associations between duration of 
PDA exposure and the development of BPD (Clyman & Hills, 2020; Clyman et al., 2020; Mirza 
et al., 2019; Schena et al., 2015).  
Last, all studies directly comparing SL to TCPC reported either validated composite 
scores of respiratory disease severity (Pulmonary score or RSS) or components thereof, such as 
?̅?aw and FiO2. While these scores are helpful to quantify the level of ventilator support and 
oxygen requirement, other important components of the mechanical ventilation strategy such as 
peak inspiratory pressure, tidal volume, PEEP, and the threshold for the transition to HFV 
remain largely unexplored. For example, Serrano et al. (2020) reported that 20% of the surgical 
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group received HFOV prior to surgery, however, ?̅?aw and FiO2 requirements were not 
statistically different between groups at baseline. HFOV was treated as a categorical variable, 
which resulted in data loss as no pressure amplitude or set frequency were reported. The use of 
categorical variables rather than actual ventilator parameters makes it difficult for the reader to 
compare ventilation strategies between groups (aside from ?̅?aw or FiO2) as no subjects in the 
TCPC group required HFOV. Collectively, all of the aforementioned investigations comparing 
SL to TCPC focused on similar primary or secondary outcomes but did not provide granular data 
insofar as ventilator parameter changes over time, ventilation and oxygenation goals, or use of 
clinical practice guidelines.  
Given the current lack of equipoise on PDA treatment, these studies represent a 
pragmatic attempt to define risk factors, operationalize outcome definitions, and inform the 
development of future randomized control trials. Large multicenter randomized control trials are 
needed to answer whether a) TCPC represents a more efficacious method of definitive closure 
than SLC; b) what is the optimal timing for repair; c) whether TCPC is more beneficial on short 
and long-term outcomes; and d) if TCPC represents an economic improvement over surgery or 
conservative management. 
In the absence of randomized control studies, retrospective and prospective database 
studies are essential to characterizing high-risk subgroups of infants such as those requiring HFV 
during the perioperative period. Therefore, it is desirable to clearly define the conventional 
ventilation strategy employed in relation to the development of respiratory decompensation 
following definitive interventions to close the PDA with the aim of early identification of high-
risk phenotypes. Furthermore, we sought to investigate temporal changes in mechanical 
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ventilation settings in the first 24-hours following PDA closure to characterize when and which 
phenotypes of infants are likely to require HFV. 
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Methods 
 
 This chapter details the methodology used for the present study and is subdivided into the 
following sections: research design, participants and population, inclusion criteria, exclusion 
criteria, data collection, measurements, and data analysis.  
Research Design 
 
The present study is a single-institution, retrospective review of the electronic medical 
record. A descriptive research design was chosen because there are no previous investigations 
examining the escalation phase of mechanical ventilation following definitive PDA closure 
between SL and TCPC. The primary outcome of interest was a 50% increase in RSS above pre-
procedure value within 24-hours following SL or TCPC was selected based upon our perception 
of clinically significant escalation of FiO2 or mechanical ventilation support.  
Participants and Population 
 
 All participants were born at outside facilities and transferred to Boston Children’s 
Hospital Neonatal Intensive Care Unit (NICU) for further management of the PDA. Subjects 
were identified from a clinical registry database maintained by the Neonatal Intensive Care Unit 
at Boston Children’s Hospital. A retrospective analysis of infants admitted to the NICU between 
January 2014 and October 2020, qualified for expedited review and was approved by the 
Institutional Review Board (IRB #P00035857).  
Inclusion Criteria 
 Enrolled participants were < 37 weeks gestational age and underwent invasive 
mechanical ventilation before and after interventions to close the PDA and received SL or TCPC 
of the PDA at Boston Children’s Hospital between January 2014- October 2020. 
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Exclusion Criteria 
 Infants with a) major congenital heart disease (aside from septal defects); b) known 
genetic or significant congenital anomalies; c) infants on non-invasive mechanical ventilation; 
and d) infants who did not undergo definitive PDA closure were excluded. 
Data Collection 
Demographic information and perinatal factors were collected from the medical record of 
each participant including gestational age, birth weight, mode of delivery, Apgar scores, gender, 
race, ethnicity, and postmenstrual age upon admission. Echocardiographic markers of HsPDA 
including the presence or absence of left-to-right flow through the PDA, PDA diameter, peak 
transductal gradient during systole, LA dilation, LV dilation, and diastolic flow reversal in the 
abdominal aorta were obtained from pre-procedure echocardiography reports.  Additionally, 
clinical information such as maternal risk factors, antenatal and postnatal steroid administration, 
surfactant replacement therapy, culture-proven sepsis, and duration of mechanical ventilation 
prior to transfer and duration of PDA exposure were obtained. Ventilator parameters, physiologic 
variables, and clinical characteristics were extracted from the electronic medical record at 
admission, pre-procedure, post-procedure, and 6, 12, and 24-hours post-procedure. As a standard 
of care, infants are managed with conventional ventilation during SL and TCPC procedure. 
High-frequency jet ventilation and high-frequency oscillatory ventilation are reserved for rescue 
therapy in the setting of refractory hypercapnia or hypoxia and have been described in previous 
publications (Wheeler et al., 2017; Wheeler et al., 2020). We routinely set HFOV frequency at 
15 Hz for preterm infants and maintain inspiratory-expiratory ratio of 1:2. 
 All PDA ligations were performed in the operating room by pediatric cardiothoracic 
surgeons. Surgical ligation was accomplished via left thoracotomy and placement of a clip or 
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ligature on the DA. All TCPC procedures were performed in the cardiac catheterization suites by 
interventional cardiology. Access was achieved via ultra-sound guidance into the femoral vein 
and advancement of the catheter into the ductus under fluoroscopy. Echocardiography and 
angiography were used to derive measurements for device selection and ensure proper 
positioning of the device within the DA. 
 All data were entered into a clinical registry database for preterm infants who underwent 
definitive PDA closure created in REDCap (Vanderbilt University, Nashville, TN). Briefly, 
REdCap (Research Electronic Data Capture) is a website that securely manages HIPAA-
sensitive information and is available to researchers affiliated with Boston Children’s Hospital. 
Several data abstraction instruments were created within REDCap and subsequently utilized to 
organize data according to the flow of information within electronic medical records 
(PowerChart, Cerner Corporation, North Kansas City, MO).  Before data collection, each 
variable was operationally defined using specified criteria with a simplified response section and 
specific data quality rules assigned to each field. Protocols for abstraction were used to facilitate 
proper coding of variables and assist chart reviewers with data collection. All data were 
internally linked to the records using the medical record number (MRN) and subject ID number. 
A master code was created and stored separately from the coded data set on HIPAA-compliant 
electronic systems that meet the standards for protected health information established by Boston 
Children’s Hospital. Data was de-identified of all protected health information before statistical 
analysis. 
Measurements 
 
Measurements included mechanical ventilator setting, monitored physiologic parameters, 
laboratory values, and calculation of ?̅?aw and RSS. Serial measurements were obtained over six 
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epochs: admission to the NICU, pre-procedure, post-procedure, and at 6, 12, and 24-hours post-
procedure. Mechanical ventilation, laboratory, and physiologic data were recorded every hour in 
the electronic medical record, and values were abstracted to reflect reported values nearest the 
event of interest (e.g. pre-procedure or post-procedure). Laboratory values were included for 
analysis provided they were reported within 1-hour, before or after the time frame of interest.  
Mean airway pressure 
 Mean airway pressure ?̅?aw = [(PIP – PEEP) x TI/Ttotal) + PEEP] 
Where PIP is peak inspiratory pressure (cm H2O); PEEP is positive end-expiratory pressure (cm 
H2O); TI is inspiratory time (seconds) and Ttotal  is total respiratory cycle time in one minute 
(Hess, 2014). Observed measurements of ?̅?aw are routinely recorded as monitored parameters 
during mechanical ventilation and were subsequently used to calculate Respiratory Severity 
Score.  
Respiratory Severity Score 
 Respiratory Severity Score (RSS) = [mean airway pressure x FiO2] is a validated non-
invasive metric used to assess the severity of respiratory failure in premature infants undergoing 
mechanical ventilation (Malkar et al., 2015). There is a strong linear correlation between OI and 
RSS (r2 = 0.982) when oxygen saturation (SpO2) is between 88% and 94% (Iyer & Mhanna, 
2013); which is the standard oxygen saturation range in the Neonatal Intensive Care Unit at 
Boston Children’s Hospital. As such, we utilized RSS to monitor and trend the severity of 
respiratory illness in preterm subjects who underwent SL or TCPC. 
Outcomes  
Our primary outcome of interest was Respiratory Decompensation; operationally defined 
as a 50% increase in RSS above pre-procedure value within 24-hours following DA ligation or 
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device closure. Secondary outcomes included a) Oxygenation failure defined as an increase in ?̅?aw 
(cm H2O) or FiO2 by 20% of pre-ligation baseline for ≥ 1-hour in the 24-hour period immediately 
following SL or TCPC; b)Ventilation failure defined as an escalation to HFV or increase of HFJV 
peak inspiratory pressure or HFOV ΔP by 20% for ≥1-hour in the 24-hour period immediately 
following SL or TCPC; c) Hypotension defined as the need to initiate a new vasoactive agent or 
an increase in dose 20% of pre-ligation baseline for ≥1-hour; and d) Post-Ligation Cardiac 
Syndrome: defined as the combination of hypotension, oxygenation failure and ventilation failure 
(Jain et al., 2012). Further, all-cause mortality during ICU admission, ICU length of stay (days), 
and reported prevalence of morbidities such as IVH, BPD, ROP, and NEC were assessed. 
Data Cleaning 
 
 Clinical data, particularly data sets which were collected retrospectively are prone to 
error and incompleteness given the systematic variation in which the data were collected and 
entered by healthcare professionals (Idri et al., 2018). To mitigate potential issues with data 
quality, the complete data set was reviewed for outliers, missing data, and errors before analysis. 
To evaluate for errors within the dataset, descriptive statistics including frequencies and ranges 
for all variables were reviewed. Minimum and maximum ranges were used to assess both 
physiologic plausibility of continuous variables and proper coding of categorical variables 
(Pallant, 2010). The application of data preprocessing (cleaning) to medical datasets has been 
shown to improve both clinical interpretation and performance of predictor variables (Mendes et 
al., 2015; Titapiccolo et al., 2012).  
Data Analysis 
The cohort was divided based upon repair type; TCPC and SL (analysis 1). A secondary 
analysis was performed to assess for differences between subjects who required post-procedural 
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HFV and those who remained on conventional ventilation.  For the secondary analysis, the 
cohort was divided based on whether the subjects underwent post-procedural HFV and compared 
with the cohort who continued to receive conventional ventilation (analysis 2). Descriptive 
statistics were used to characterize the sample and assess the distribution of continuous variables 
(e.g. skewness and kurtosis). Normality of data was assessed using the “Explore” command in 
SPSS, which allows for data visualization (e.g. histograms and Q-Q plots) and analysis of 
normality using the Kolmogorov-Smirnov and Wilk-Shapiro tests (Pallant, 2010).  For normally 
distributed data, continuous variables were summarized using means and standard deviations and 
compared using an unpaired t-test. Non-normal distributions are described using median (Mdn) 
and interquartile range (IQR) and compared using the Mann Whitney U-test. Categorical 
variables were summarized using frequencies, percent’s and proportions and compared using 
chi-square or Fisher’s exact test as appropriate.  The Holm-Sidak procedure was used to account 
for multiple comparisons and to preserve type 1 error rate via multiplicity adjusted P values 
(Staffa & Zurakowski, 2020).  Data analysis was performed with SPSS Statistics 24 (IBM, 
Armonk, NY) and Prism (GraphPad version 8, La Jolla, CA). All tests were two-sided and P 
values <.05 were considered significant. 
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Results and Findings 
 A total of 168 infants who underwent definitive PDA closure were identified, of which 
110 subjects were eligible for the study (Appendix H). All subjects were referred for PDA 
closure following the failure of or contraindications to pharmacologic treatment. The presence of 
PDA was confirmed by echocardiography in all participants within 2-days of definitive 
intervention. There was a 4:1 ratio of infants who underwent SL (n = 88) to TCPC (n = 22). 
Subjects in both groups were similar for sex, gestational age, birth weight, and other perinatal 
factors (Appendix I). Infants in the TCPC group were older at the time of the procedure and 
underwent mechanical ventilation for twice as many days prior to referral. Additionally, the 
TCPC group had a larger ductal diameter, longer duration of exposure to HsPDA, and higher 
prevalence of left ventricle dilation via echocardiogram.  
Table 5.  
 
Mechanical Ventilation and Physiologic Variables Upon Admission 
 
 
Variable 
SL  TCPC 
P value 
(n = 88)  (n = 22) 
     
CMV PIP, cm H2O 20 (18-23)  24 (21-26) .018* 
VT, mL/kg 6.5 (6-8)  7 (6-9) .68 
f , breaths/min 31 (28-40)  30 (26-35) .56 
PEEP, cm H2O 6 (5-6)  7 (7-8.5) .006** 
FiO2 .4 (.30-.6)  .4 (.40-.93) .22 
pH 7.23 (7.17-7.28)  7.32 (7.25-7.37) .006** 
PCO2, mm Hg 63 (55-72)  60 (46-71) .76 
HFV 14 (16%)  4 (18%) .97 
 
Note. CMV PIP = conventional mechanical ventilation peak inspiratory pressure, VT = exhaled 
tidal volume, PEEP = positive end-expiratory pressure, f = set respiratory rate, SpO2 = oxygen 
saturation, PCO2 = partial pressure of carbon dioxide via blood gas, HFV = high-frequency 
ventilation. * p < .05. ** p < .01. 
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Mechanical Ventilation and Physiologic Variables at NICU admission 
Several differences in mechanical ventilation parameters and physiologic data were 
observed between groups at NICU admission.  Subjects in the TCPC group exhibited higher 
median RSS 5.4 IQR (4-13) vs. 3.8 IQR (3-6), p = .024 and ?̅?aw 13 cm H2O IQR (11-15) vs. 10 
cm H2O IQR (8-11), p = .006, respectively. Median PEEP, PIP, and pH were also higher in 
TCPC group. HFV requirement and other respiratory variables were similar at admission 
between groups and are displayed in (Table 5). 
Assessment of Post-procedural Respiratory and Cardiovascular Outcomes 
Our primary outcome of interest, an increase in RSS > 50 % above pre-procedural values 
was similar between groups at post-procedure and 6-hours. Twelve-hours after closure of the 
DA, 40% of the SL group demonstrated RSS > 50% above pre-procedural values, compared with 
3% of the TCPC group (p = .021). No differences were observed between groups for secondary 
outcomes including PIP > 20%, ?̅?aw >20%, FiO2 >20%, hypotension and PCLS. Post-
procedural outcomes data are presented in Table 6. 
Analysis 1: Comparison of Post-procedural Respiratory Decompensation 
 The TCPC group was characterized by elevated PEEP during all measurements from 
NICU admission to 24-hours. ?̅?aw was higher in the TCPC group from admission through 12-
hours post-procedure. Moreover, elevated RSS and FiO2 persisted in the TCPC group from 
admission to post-procedural measurements and were similar to the surgical group for all 
subsequent measurements. Further, the TCPC group required higher CMV PIP for all 
measurements with statistically significant differences at admission, 6,12, and 24-hours post-
procedure. Notably, for infants who underwent TCPC, RSS was similar to pre-procedural values 
within 6-hours of procedure; whereas, RSS increased in the SL group from 12 to 24-hours 
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(Appendix J). A larger proportion of the SL group received HFV ventilation at 24-hours 
compared with subjects who underwent TCPC (43% vs. 5%, p = .004). Temporal trends in 
mechanical ventilation and physiologic variables over all time periods are displayed in 
(Appendix K). 
Table 6.  
 
Respiratory Severity Score, Mechanical Ventilation and Physiologic Outcomes 
 
 
Variable 
SL  TCPC  
P 
(n = 88)  (n = 22)  
 
RSS > 50% 
     
Post-procedure 23 (26%)  7 (32%)  .59 
6-hours  22 (25%)  4 (18%)  .50 
12-hours  35 (40%)  3 (14%)  .021* 
24-hours  28 (32%)  3 (14%)  .09 
PIP > 20% 5 (6%)  4 (18%)  .08 
?̅?aw >20% 27 (31%)  6 (27%)  .75 
FiO2 >20% 68 (77%)  15 (68%)  .37 
Hypotension 16 (18%)  1 (5%)  .19 
PCLS 8 (9%)  1 (5%)  .68 
Results are presented as n %. RSS = Respiratory Severity Score, SL = Surgical ligation, TCPC = 
Transcatheter PDA Closure, PIP = peak inspiratory pressure, ?̅?aw = mean airway pressure, FiO2 = 
Fraction of Inspired Oxygen, PCLS = Post cardiac ligation syndrome. *p-value < .05. 
 
Outcomes at Disposition 
 Survival to discharge was 97% to 100% for SL and TCPC, respectively. Life support was 
withdrawn in three subjects in the SL group as a result of surgical NEC and sepsis; all of which 
occurred >25 days post-procedure.  No statistical differences were observed between groups for 
reported medical or surgical NEC, ROP ≥ stage 2, PMA at discharge, and weight at discharge. 
More infants in the TCPC group met the criteria for BPD ≥ grade 3, however, this did not 
achieve statistical significance. Subjects in the TCPC group had a shorter ICU length of stay (4 
days vs. 7 days, p = .017) and were larger at discharge (1115 g vs. 1440 g, p = .033). Twenty 
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subjects (91%) in the TCPC group were mechanically ventilated and 2 (9%) were supported with 
CPAP at the time of retro-transfer. For the SL group, 61 (72%) remained mechanically 
ventilated, 10 (12%) were supported with CPAP, 6 (7%) low-flow nasal cannula, and 8 (9%) 
were in room air at the time of transfer.  Outcomes at disposition are displayed in Table 8. 
Table 8.  
 
Outcomes and Morbidity at Disposition 
 
 SL 
(n = 88) 
 TCPC 
(n = 22) 
 P 
Outcome  
Survived to DC 85 (97%)  22 (100%) .99 
ICU Length of Stay 7 (4-41)  4 (2-15) .017* 
NEC, medical 11 (13%)  2 (9%) .99 
NEC, surgical 17 (19%)  1 (4.5%) .12 
ROP ≥ stage 2 9 (10%)  5 (23%) .12 
BPD ≥ grade 3 7 (8%)  5 (23%) .047 
PMA at discharge, weeks 30.7 (28.7-34.2)  31.4 (28.8-35.7) .22 
Weight at discharge, g 1115 (865-1685)  1440 (1027-2325) .033* 
Note.  DC = discharged from hospital or retro-transfer to referring center, ICU = intensive care 
unit, NEC = necrotizing enterocolitis, ROP = retinopathy of prematurity, BPD = 
bronchopulmonary dysplasia, and PMA = postmenstrual age. *p < .05. 
 
Analysis 2: Comparison of subjects who required post-procedural HFV 
 
Eighteen subjects were managed with HFV at admission, of which 8 continued to receive 
HFV post-procedure; 6 SL and 2 TCPC. Forty-eight subjects underwent HFV within 24-hours 
post-procedure and 62 were managed with conventional mechanical ventilation.  Subjects who 
required HFV post-procedure were younger, more likely to be male, underwent definitive PDA 
closure earlier, and had smaller ductal diameter on echocardiogram (Table 9). Subjects who 
underwent post-procedural HFV demonstrated escalation of median RSS from pre-procedure 
through 24-hours, higher ?̅?aw and FiO2 at 6, 12, and 24-hours post-procedure compared with the 
CMV cohort.  Median pH was lower in the HFV group for all measurements and statistically 
significant from 6-hours through 24-hours post-procedure (Appendix L). Subjects managed with 
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HFJV (n= 38) had higher PEEP levels compared with the CMV group at 6, 12, and 24-hours 
post-procedure. HFJV on-time was maintained at 0.02 seconds with frequency at 7 Hz in all 
except two subjects; who were managed on 6 Hz with HFJV on-time 0.024 seconds.  Median 
HFJV PIP and IQR was 22 (20-25.5), 22 (20-26), 26 (23-29) and 27.5 (23-30) for post-
procedure, 6-hours, 12-hours and 24-hours, respectively. Ten subjects were managed on HFOV, 
median amplitude (P) and IQR was 27 (24-30), 26 (24-30), 28 (24-32), and 27 (22-55) for post-
procedure, 6-hours, 12-hours, and 24-hours, respectively.  
Table 9.  
 
Demographics: High-Frequency Ventilation vs. Conventional Mechanical Ventilation 
Variable 
HFV  
(n = 48) 
CMV 
(n = 62) 
P  
Procedure type    
TCPC 4 (8.3%) 18 (29%) 
.008* 
Surgical ligation 44 (91.7%) 44 (71%) 
Gestational Age, weeks 25 (24, 26) 26 (24, 27) .01* 
Weight, kg 0.72 (0.59, 0.82) 0.77 (0.65, 0.9) .073 
Duration of MV, pre-
admission 12 (7, 23) 19 (8, 27) .075 
PDA closure, day of life 19 (14, 26) 25 (18, 41) .003** 
PDA diameter, mm 2.5 (2, 3) 3 (2.5, 3.5) .014* 
Sex    
Female 16 (33.3%) 34 (54.8%) 
.034* 
Male 32 (66.7%) 28 (45.2%) 
PMA at admission, weeks 27 (25, 29) 29 (27, 32) .001** 
Note. Data are presented as n (%) or Mdn and IQR. HFV = high-frequency ventilation, CMV = 
conventional mechanical ventilation, TCPC = transcutaneous percutaneous device closure, PDA 
= patent ductus arteriosus, PMA = post-menstrual age. *p < .05. **p < .01. 
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Discussion, Recommendations, and Conclusion  
 
Discussion 
 
The present study aimed to assess differences in post-procedural respiratory 
decompensation in a cohort of mechanically ventilated subjects who underwent SL or TCPC. 
The primary finding from our study is that 40% of infants who underwent SL demonstrated RSS 
(> 50%) above pre-procedural values at 12-hours post-procedure compared to 14% of the TCPC 
group, (p <.021). Moreover, 43% of the SL group was transitioned to HFV by 12-hours post-
procedure and remain on HFV through 24-hours. Both groups were similar for sex, birthweight 
and gestational age, and other perinatal factors. The TCPC group was associated with older age 
at the procedure, longer duration of mechanical ventilation before PDA closure, larger PDA 
diameter, and LV dilation. Postmenstrual age was similar between groups at the time of transfer 
back to the referring center, however, TCPC was associated with a shorter length of stay on our 
unit. 
Several investigations have found improvements in pulmonary status including a more 
rapid return to baseline RSS and shorter duration of mechanical ventilation in infants who 
underwent TCPC as compared to SL (Hazeem et al., 2013; Rodriguez-Ogando et al., 2018; 
Sathanandam et al., 2018; Balduf, et al., 2019). While we did not precisely measure the time of 
return to baseline RSS, infants in the TCPC group with clinically significant respiratory 
decompensation (exceeding RSS >50%) peaked at post-procedure and declined thereafter; in 
contrast, RSS >50% progressively increased in the SL cohort from 6 to 12-hours. These findings 
suggest that subjects who underwent TCPC exhibited a precipitous return toward baseline RSS 
within 6-hours of procedure in comparison to their surgical counterparts that demonstrated 
progressively higher levels of respiratory support from 6 to 12-hours post-procedure. 
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 Although, the avoidance of thoracotomy and instrumentation of the lung to access the 
DA for ligation may be partially responsible for the observed differences in respiratory 
decompensation between groups; it is also plausible that larger PDA diameter (3.3 mm vs. 2.5 
mm, p = .002) and a higher of proportion of LV dilation (91% vs. 67%, p = .033) in the TCPC 
group may have contributed to improvements in post-procedural RSS. Krishnappa and 
colleagues (2019) reported on echocardiographic indices of PDA size and LV dilation as 
predictors of early extubation in a cohort of surgical ligated preterm infants dependent on 
mechanical ventilation. After adjustment for confounders, multivariable analysis demonstrated 
that PDA size > 2.5 mm aHR 0.51, 95% CI [0.36, 0.72] and LV dilation z score ≥ 2 aHR 0.61, 
95% CI [0.42, 0.87] were independent predictors of early weaning and extubation. Therefore, it’s 
conceivable that infants with larger PDA diameter and LV dilation may be more likely to have 
greater improvement in pulmonary compliance following ductal closure which facilitates 
weaning mechanical ventilation.  
 Unlike previous studies comparing SL to TCPC, we excluded all subjects who did not 
require invasive mechanical ventilation upon admission to assess differences between subjects 
who continued to receive conventional mechanical ventilation from those who underwent post-
procedural HFV. There is a paucity of studies describing temporal escalation of RSS in context 
with the timing, level, or type of mechanical ventilation support in premature infants undergoing 
definitive PDA closure.  Our findings are supported by Santhanandam et al. (2018), who 
reported a lower RSS delta change (18% vs. 76%, p <.01) for TCPC and SL, respectively. 
Additionally, these authors found that RSS was higher at baseline (3.9 vs. 2.8, p = .18) for TCPC 
and SL respectively. Importantly, post-procedural escalation of RSS was more pronounced in 
infants who underwent TCPC ≥ 8 weeks postnatal age, compared with those who received TCPC 
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≤ 4weeks (5.4 vs. 3.4, p = .01). In the present study, median postnatal age at procedure was 29.5 
days (>4 weeks) and may partially explain why the TCPC group required higher respiratory 
support (PIP, PEEP, ?̅?aw) than the less mature SL group. Infants in the TCPC group had longer 
exposure to HsPDA and underwent mechanical ventilation for twice as long; both of which have 
been associated with the development of BPD, however, causality has yet to be irrevocably 
determined (Clyman & Hills, 2020; Mirza et al., 2019; Schena et al., 2015).  Collectively, these 
findings suggest that if TCPC is performed at an earlier age (e.g. < 4 weeks) it may be possible 
to mitigate prolonged exposure to and escalation of mechanical ventilation parameters. However, 
size limitations (Piccolo device is FDA approved for preterm infants >700g), ductal morphology 
and infection status may prevent some infants from being candidates for TCPC (Backes et al., 
2016; Backes et al., 2019). 
The secondary analysis compared subjects who remained on conventional ventilation to 
those who underwent HFV within 24-hours of PDA procedure. Our findings suggest that HFV 
after PDA closure is associated with SL, smaller gestational age, male sex, younger age at PDA 
closure, smaller duct diameter, lower PMA at admission, and higher RSS from admission 
through 24-hours.  Gestational age < 26 weeks, birthweight < 1kg, PDA size, PDA procedure at 
< 28 postnatal days contribute to post-procedural cardiorespiratory instability and are established 
risk factors for the development of cardiopulmonary decompensation, chronic lung disease or 
death (El-Khuffash et al., 2013; Jain et al., 2012; P. J. McNamara et al., 2010; Natarajan et al., 
2010; Teixeira et al., 2008).  Consistent with these findings, subjects who required escalation to 
HFV post-procedure were younger, underwent PDA closure earlier, and were more likely to 
have undergone SL. Moreover, our finding that male sex was associated with HFV is consistent 
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with previous reports which suggested that female infants on average have lower respiratory 
morbidity and mortality compared to their male counterparts (Townsel et al., 2017).  
Several authors have described derangement of oxygenation or ventilation status and 
escalation of RSS following PDA ligation (Francis et al., 2011; Hsu et al., 2019; Seo et al., 2020; 
Ting et al., 2016). Our findings are corroborated by Seo et al. (2020), who compared the 
respiratory parameters in a cohort of preterm infants who underwent PDA ligation (Mdn 22 days 
postnatal age) based on the binary outcome of prolonged ventilation >14 days vs. successful 
extubation in < 14 days. These authors found that less mature infants with lower birthweights 
were more likely to receive HFOV before (62% vs. 13%, p =.004) and after (67 % vs. 7 %, p 
<.001) PDA closure. Francis and colleagues (2013) evaluated temporal trends in respiratory and 
cardiovascular morbidity within 48-hours of SL and reported median baseline RSS 4.6 (3-6.1) 
and post-operative RSS 6 (3.5-8).  Similar to the present study, RSS >50% was reported in 48% 
of infants following ligation and peaked at 42% by 12-hours. Currently, Serrano et al. (2019) is 
the only report which described post-procedural HFV requirement between SL and TCPC. These 
investigators found that 20% of infants who underwent SL received HFOV and observed no 
HFV requirement in the TCPC group. Further, the SL group demonstrated a higher post-
procedural FiO2 (0.64 vs.0.43, p = .004) and a larger total change in peak FiO2 (0.23-0.9, p = 
.008).  These results underscore our findings that infants who underwent SL are more likely to 
present with respiratory decompensation within 12-hours of ligation and require rescue HFV 
more frequently than infants who underwent TCPC.  
Strengths of the present study include a moderate sample size of mechanically ventilated 
preterm infants who underwent SL or TCPC at a large quaternary care center. To the best of our 
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knowledge, the current study is the first to compare temporal escalations of conventional 
mechanical ventilation and timing of transition to HFV between SL and TCPC.   
There are several potential limitations to the present investigation. First, this is a 
retrospective, study in a single-center over an approximately 6-year period. The retrospective 
design is uncontrolled and uses existing data from the electronic medical record which were 
initially captured for purposes other than research. Therefore, one of the largest threats to internal 
validity is data that is missing or inaccurately documented. With this in mind, we purposely 
selected RSS to limit missing data, as mean airway pressure and FiO2 are frequently recorded in 
the medical record. Second, SL for premature infants was the standard of care for HsPDA in 
infants who were unresponsive or not candidates for pharmacological treatment, until the Piccolo 
device received FDA approval in 2019 (Backes et al., 2019). Therefore, the ratio of infants who 
received ligation vs. TCPC was uneven (4:1) given the temporal changes in PDA management. 
Finally, we recognize that there may be other meaningful time points to consider beyond 24-
hours of age. However, infants demonstrating stability following SL or TCPC are generally 
retro-transferred to the referring hospital within 48-hours of PDA procedure; whereas those who 
require HFV or escalated ventilator settings will have a longer LOS at Boston Children’s 
Hospital. As such, we have reviewed short-term outcomes to better understand the escalation and 
phase of mechanical ventilator titration.  
Recommendations 
The management of preterm infants with PDA, such as timing and method of closure 
continues to be a contentious topic and is unlikely to be settled in the absence of well-designed 
randomized control trials.  Nevertheless, we aim to further describe the prevalence of respiratory 
decompensation in both SL and TCPC with the aim of identifying high-risk phenotypes for 
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future research. Current initiatives include logistic regression modeling to further define risk 
factors for HFV and the development of a clinical score to assist bedside providers in the 
decision to utilize rescue HFV. Future projects will include validation of the clinical score and 
prospective collaboration with referral hospitals to assess long-term outcomes. 
Conclusion 
In this study, we found that respiratory decompensation following closure of the PDA was 
associated with younger gestational age, younger age at PDA closure, surgical ligation, and 
elevated RSS values over the first 12 hours after closure. These results confirm prior data, but 
also suggest that an elevated RSS following PDA closure may be a useful non-invasive bedside 
tool to identify the respiratory phenotype of post ligation cardiac syndrome.   
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APPENDICES 
Appendix A 
 
Figure 1. Physiologic Manifestations of Prolonged Left-to-Right Shunt 
 
 
  
Figure 1. Schematic of the physiologic impact of prolonged exposure to left-to-right shunt from 
hemodynamically significant PDA. Pulmonary blood flow is increased as a result of blood being 
diverted from the systemic to pulmonary circulation. Importantly, the presence of a large shunt 
reduces left-ventricle afterload and the increases LV preload. The increase in blood flow to the 
pulmonary arteries and veins results in left atrial and ventricular dilation. Moreover, prolonged 
exposure to elevated pulmonary artery pressures can be the catalyst for pulmonary vascular 
remodeling and increased pulmonary vascular resistance. PDA = patent ductus arteriosus, PA = 
pulmonary artery, PV = pulmonary vein, LA = left atrium, LV = left ventricle. Reprinted with 
permission from “Patent Ductus Arteriosus in preterm infants: is early transcatheter closure a 
paradigm shift?” by P. Vali, S. Lakshminrusimha, A. Pelech & F.Ing, 2019, Journal of 
Perinatology, 38, p. 1454. Copyright 2019 by Satyan Lakshminrusimha. 
 
 
 
 
 
   
66 
 
Appendix B 
Figure 2. A Comparison of Fetal and Postnatal Circulation
 
Figure 2. Schematic diagram of intrauterine and extrauterine circulation (a) fetal circulation is 
depicted (b) denotes neonatal circulation after birth. RA = right atrium, LA = left atrium, RV = 
right ventricle, LV = left ventricle, PVR = pulmonary vascular resistance. Reprinted with 
permission from “Patent Foramen Ovale,” by Homma et al., 2016, Nature reviews, 2, p. 1. 
Copyright 2016 by Macmillian Publishers Limited 
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Appendix C 
Figure 3. Factors Which Contribute to Hemodynamic Significant PDA 
 
Note. A comprehensive multi-modal evaluation using several different technologies and 
biomarkers allow for a more thorough estimation of PDA impact on organ function. LVO = left 
ventricular output, BNP = B-type natriuretic peptide, NT-pro-BNP = N-terminal pro-B-type 
natriuretic peptide, cTnT = cardiac troponin T. Reprinted with permission from “Defining 
‘Haemodynamic Significance’ of the Patent Ductus Arteriosus: Do We Have All the Answers,” 
by A. Smith, and A.F EL-Khuffash, 2020, Neonatology, p. 4. Copyright 2020 by Karger AG. 
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Appendix D 
 
Figure 4. Schematic of the Relationships Governing Blood Flow Through a Vessel 
 
Figure 4.  (A) Poiseuille’s equation describes the relationship between flow and pressure during 
laminar flow. Q = flow, ΔP = pressure gradient P2 - P1; 𝜋 = 3.14, d = diameter4, μ = dynamic 
viscosity, and L = vessel length. At a constant pressure gradient, the magnitude of blood flow 
through a vessel is determined by the resistance. Resistance is most influenced by small changes 
in vessel diameter. (B) Bernoulli’s Principle states that blood flow velocity and pressure drop 
through a lesion (e.g. PDA) is related to flow rate and cross-sectional area of the vessel. u1 = low 
velocity, u2 = high velocity. Reprinted with permission from “Mechanical Concepts Applied in 
Congenital Heart Disease and Cardiac Surgery,” by R. B. Gerrah, S. J. Haller, and I. George, 
2017, Annals of Thoracic Surgery, 103, p. 2007. Copyright 2017 by The Society of Thoracic 
Surgeons. 
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Appendix E 
 
Figure 5. Physiologic Manifestations of Post Cardiac Ligation Syndrome 
 
 
 
Figure 5. Schematic of the physiologic manifestations of post cardiac ligation syndrome.  
Ligation of the PDA results in an immediate decrease in pulmonary blood flow, increased LV 
afterload and concurrent reduction of LV preload. The premature myocardium is unable to 
handle this abrupt change in loading conditions and may be further limited by coronary 
hypoperfusion, ventricular dysfunction and systemic hypoperfusion. PDA = patent ductus 
arteriosus, PA = pulmonary artery, Qp = pulmonary blood flow, PV = pulmonary vein, LA = left 
atrium, LV = left ventricle, EF = ejection fraction. Reprinted with permission from “Patent 
Ductus Arteriosus in preterm infants: is early transcatheter closure a paradigm shift?,” by P. Vali, 
S. Lakshminrusimha, A. Pelech & F. Ing, 2019, Journal of Perinatology, 38, p. 1454. Copyright 
2019 by Satyan Lakshminrusimha. 
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Appendix F 
 
Figure 6. Transcatheter PDA Closure 
 
 
Figure 6. Schematic denoting the transvenous approach for transcatheter closure of the PDA. Access is obtained via 
the femoral vein and the catheter is advanced up the inferior vena cava to the right atrium, across the tricuspid valve, 
the right-ventricle, across the pulmonary valve, pulmonary artery and finally into the PDA. The device is 
subsequently deployed in the PDA under echocardiography and fluoroscopic guidance. RA = right atrium, RV = 
right ventricle, LA = left atrium, LV = left ventricle, EF = ejection fraction. Reprinted with permission from 
“Percutaneous Closure of the Patent Ductus Arteriosus in Very Low Weight Infants: Considerations Following US 
Food and Drug Administration Approval of Novel Device” by C. H. Backes et al., 2019, Journal of Pediatrics, 213, 
p. 219. Copyright 2019 by Elsevier. 
  
 
 
 
 
 
 
 
Appendix G 
 
 
Table 3.  
Data are presented as median, interquartile range or mean ± standard deviation. SL = surgical ligation, TCPC = 
transcatheter PDA closure, RSS = respiratory severity score, FiO2 = fraction of inspired oxygen, HFOV = high-
frequency oscillatory ventilation, VLBW = very low birthweight infant (< 1500 grams) and PCLS = post cardiac 
ligation syndrome 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Comparison of Respiratory Outcomes Between Surgical Ligation and TCPC 
First author N Age, weeks Weight, kg Design Primary Outcome Measured 
      
Hazeem  
SL 
TCPC 
 
16 
8 
8 
 
29 (23-37) 
29.8 (24-39) 
 
 
2.8 (2.3-4.2) 
1.55 (0.52-2.97) 
 
Single-center, retrospective 
case-control, matched-pairs, 
comparison of mechanically 
ventilated infants < 4kg 
Median time of return to baseline RSS 
SL: 53 hours (13-219) vs. TCPC: 17 hours (0-
113), p <.05. Baseline RSS was 2.6 (1.4–6) and 
4.4 (1.3-14.6) for SL and TCPC respectively 
 
Ogando  
SL 
TCPC 
 
78 
53 
25 
 
25.8  2 
26.5  1.2 
 
0.79  0.25 
0.92  0.22 
 
 
Single-center, retrospective 
comparison of infants 
requiring mechanical 
ventilation  
Pulmonary score decreased in both groups 
(linear mixed effect model, p <.001 
TCPC group had a more rapid recovery, 
beginning immediately after ductal closure vs. 7 
days in SL group 
 
Regan  
SL 
TCPC 
 
 
 
147 
83 
64 
 
25.3 (24.7-26.9) 
25.6 (24.7-27.0) 
 
0.76 (0.69-0.98) 
0.78 (0.70-0.95) 
Multicenter, retrospective, 
matched-pairs (2:1), case-
control study of respiratory 
outcomes in infants < 3kg 
Duration of mechanical ventilation was shorter 
in TCPC group 3 (0-7) compared with SL 5 (2-
14) days, p = .035. This effect was more 
pronounced if ductal closure was completed 
prior to 4 weeks (3 vs. 9 days, p = .022) 
Sathanandam 
SL 
TCPC 
 
120 
40 
80 
 
25 (23-27) 
25 (23-27) 
 
0.69 (0.56-0.97) 
0.70 (0.57-0.83) 
 
Retrospective, propensity-
score matched (2:1) study of 
infants to evaluate changes 
in RSS (before/after 
intervention) 
Greater increase in RSS following SL compared 
with TCPC (76% vs. 18%,  p < 0.01). Longer 
time to return to baseline RSS following SL 
compared with TCPC (28 vs. 8.4 hours,  p <.01) 
Serrano  
SL 
TCPC 
84 
59 
25 
 
25.9  1.8 
25.2  1.79 
 
0.79  0.28 
0.76  0.18 
Retrospective, cohort study 
of VLBW infants to 
evaluate escalation of 
respiratory support and 
PCLS 
SL higher need for hemodynamic support than 
TCPC (20 % vs. 0, p = .016); higher post-
procedure FiO2 (0.64 vs. 0.43, p = .004; and 
absolute change in FiO2 (0.23 vs. 0.09, p=.008). 
20% of SL required HFOV 
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Appendix H 
 
Figure 7. Flow Diagram of Included and Excluded Subjects 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. CHD = Congenital Heart Disease 
 
 
 
 
 
 
 
 
 
 
 
Included for analysis 
 (n = 110) 
 
Excluded (n = 58) 
 
Complex CHD (n = 22) 
 
Not mechanically ventilated  
(n = 16) 
 
>37 weeks gestation 
(n = 17) 
 
Major Congenital Anomalies  
(n = 2) 
 
PDA re-intervention  
(n = 1) 
 
 
 
 
Surgical Ligation  
(n = 88) 
Transcatheter Device Closure 
 (n = 22) 
Subjects admitted for PDA closure 
 (n = 168) 
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Appendix I 
 
Table 4.  
Demographics and Perinatal Factors Between Groups 
 SL TCPC 
P value 
Variable (n = 88) (n = 22) 
Sex 
   Male 
   Female 
 
52 (59%) 
36 (41%) 
 
14 (64%) 
8 (36%) 
 
.81 
Gestational Age, weeks  25.1 (24.1-26.3) 25.6 (24.9-27.0) .17 
PMA, weeks  27.9 (26.1-29.4) 30.1 (28.5-35.2) .001** 
Extremely premature  
Very premature 
81 (92%) 
7 (8%) 
20 (91%) 
2 (9%) 
.65 
.99 
Birthweight, g 750 (640-895) 663 (581-810) .12 
     ELBW, < 1000g 81 (92%) 17 (77%) .061 
     VLBW, < 1500g 5 (6%) 4 (18%) .08 
     LBW, < 2500g 2 (2%) 1 (5%) .49 
Apgar, 1 minute 3 (1-6) 3.5 (2-6) .36 
Apgar, 5 minutes 7 (4-8) 6.5 (5-8) .59 
Surfactant  81 (92%) 20 (91%) .99 
Cesarean 63 (72%) 15 (68%) .79 
IUGR 6 (7%) 1 (5%) .99 
Antenatal Steroids  18 (46%) 7 (50%) .27 
Postnatal Steroids 30 (34%) 10 (47%) .33 
IVH ≥ Grade 3  21 (24%) 2 (9%) .15 
Medical NEC 11 (13%) 2 (9%) .99 
Surgical NEC 17 (19%) 1 (5%) .17 
Ventilator duration, days 13 (6.2-23.8) 26 (21-48) .001** 
Ventilator mode 
     CMV 
     HFV 
 
75 (85%) 
13 (15%) 
 
18 (82%) 
4 (18%) 
.74 
PDA diameter, mm  2.5 (2.2-3.0) 3.3 (2.9-3.7) .002** 
PDA procedure, daya 20 (14-27) 29.5 (23-55) .001** 
Left-to-right shunt 84 (95%) 20 (90%) .34 
Dilated LA 66 (75%) 20 (95%) .15 
Dilated LV 59 (67%) 20 (91%) .033** 
Systolic gradient, mm Hg 20 (15-25) 25 (14.8-35) .33 
Flow reversalb  60 (68%) 17 (77%) .45 
 Data are presented as median (interquartile range) for continuous variables and n % for categorical variables. P 
values were calculated using Fisher's exact test or the Mann-Whitney U test. PMA = Post menstrual age at NICU 
admission, ELBW = extremely low birthweight infant, VLBW= very low birthweight infant, LBW = low birthweight 
infant, IUGR = intrauterine growth restriction, IVH = intraventricular hemorrhage, NEC = necrotizing enterocolitis, 
CMV = conventional mechanical ventilation, HFV = high-frequency ventilation, LA = left atrium, LV = left ventricle. 
*p < .05. ** p < .01. 
 
a Day of life PDA closure was performed.  
 
b Flow reversal = echocardiographic observation of flow reversal during diastole in the descending aorta 
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Appendix J 
 
Figure 8. 
 
Temporal Trends in Respiratory Severity Score  
 
 
 
Figure 8. Data presented as Mdn and IQR. RSS = Respiratory Severity Score, TCPC = 
transcatheter PDA closure. * p < .05. 
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Appendix K 
 
Table 7.  
Mechanical Ventilation and Physiologic Characteristics: SL vs. TCPC 
 
 
 
SL 
(n = 88) 
 
TCPC 
(n = 22) 
 
P Variable 
 
Pre-procedure    
RSS 3.8 (2.8-5.9) 5.4 (4.1-13) .024* 
CMV PIP, cm H2O 21 (19-23) 23 (20-26) .063 
VT, mL/kg 6 (5-8) 7 (6-8) .50 
f , breaths/min 35 (28-40) 32 (28-38) .56 
PEEP, cm H2O 6(6-7) 7 (6-8) .002** 
FiO2 .3 (.25-.40) .4 (.3-.46) .020* 
?̅?aw, cm H2O 10 (9-11) 11.5 (10-14) .001** 
pH 7.27 (7.23-7.32) 7.31 (7.25-7.35) .13 
PCO2, mm Hg 60.5 (53-67) 58 (46-71) .94 
HFV, n % 6 (18%) 2 (9%) .97 
Post-procedure    
RSS 3.1 (2.3-4.2) 4.2 (3.2-5.9) .020* 
CMV PIP, cm H2O 21 (19-23) 23 (20-27) .055 
VT, mL/kg 7 (6-8) 7 (6-9) .68 
f , breaths/min 36 (32-40) 34 (28-40) .31 
PEEP, cm H2O 6 (6-6) 7 (6-7) .003** 
FiO2 .35 (.3-.5) .47 (.40-.63) .02* 
?̅?aw, cm H2O 10 (9-11) 11.5 (11-14) .001** 
pH 7.28 (7.17-7.37) 7.31 (7.23-7.39) .31 
PCO2 mm Hg 58 (46-71) 59 (45-69) .94 
HFV, n % 16 (18%) 3 (14%) .97 
6-hours    
RSS 3.6 (2.5-5) 4.4 (3.3-5.4) .34 
CMV PIP, cm H2O 21 (19-22) 23 (22-32) .006** 
VT, mL/kg 7 (6-8) 8 (6-10) .09 
f , breaths/min 38 (34-40) 36 (36-40) .30 
PEEP, cm H2O 6 (6-6) 7 (6-7) .003** 
FiO2 .35 (.28-.49) .40 (.30-.45) .71 
?̅?aw, cm H2O 10 (9-11) 12 (11-13) .006** 
pH 7.27 (7.18-7.32) 7.32 (7.25-7.36) .053 
PCO2, mm Hg 59 (50-68) 60 (50-64) .94 
HFV, n % 24 (27%) 3 (14%) .27 
12-hours    
RSS 4.4 (2.7-6.3) 4.2 (3.4-6.3) .65 
CMV PIP, cm H2O 22 (19-23) 23 (22-27) .011* 
VT, mL/kg 8 (7-10) 9 (7-9) .68 
f , breaths/min 36 (32-40) 33 (29-37) .20 
PEEP, cm H2O 6 (5-6) 7 (6-7) .003** 
FiO2 .40 (.30-.53) .41 (.30-.49) .74 
?̅?aw, cm H2O 11 (10-12) 13 (10-14) .005** 
pH 7.27 (7.21-7.34) 7.34 (7.28-7.37) .13 
PCO2, mm Hg 56 (49-67) 56 (50-63) .94 
HFV, n % 38 (43%) 4 (18%) .048 
24-hours    
RSS 4.5 (2.9-6.6) 4.8 (3.7-6.1) .65 
CMV PIP, cm H2O 21 (18-23) 24 (22-28) .004** 
VT, mL/kg 7 (6-8) 7 (7-9) .68 
f , breaths/min 34 (30-40) 32 (27-38) .56 
PEEP, cm H2O 6 (6-6) 7 (6-8) .003** 
FiO2 .40 (.30-.53) .40 (.35-.55) .71 
?̅?aw, cm H2O 11 (9-13) 12 (10-13.5) .14 
pH 7.32 (7.24-7.36) 7.33 (7.31-7.37) .13 
PCO2, mm Hg 55 (48-62) 53 (44-57) .88 
HFV, n % 38 (43%) 1 (5%) .004** 
 
Table 7. Results are presented as median (interquartile range). SL = surgical ligation, TCPC = transcatheter PDA closure, CMV PIP = 
conventional mechanical ventilation peak inspiratory pressure, VT = exhaled tidal volume, PEEP = positive end-expiratory pressure, f = set 
respiratory rate, FiO2 = Fraction of Inspired Oxygen, ?̅?aw = mean airway pressure, SpO2 = oxygen saturation, PCO2 = partial pressure of carbon 
dioxide via blood gas, HFV = high-frequency ventilation. *p <.05. **p <.01. 
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Appendix L 
 
Table 10.  
 
Comparison of Post-procedural CMV with HFV 
 CMV 
(n = 62) 
HFV 
(n = 48) 
P 
Variable  
Post-procedure    
PEEP, cm H2O 6 (6-7) 6 (6-8) .27 
?̅?aw, cm H2O 10 (9-11) 11 (10-12) .07 
FiO2 .36 (.30-.50) .40 (.30-.57) .06 
RSS 3.7 (2.7-5) 4.2 (3.1-7.1) .022* 
pH 7.30 (7.24-7.38) 7.25 (7.13-7.38) .34 
PCO2, mm Hg 59 (46-68) 58 (44-72) .90 
6-hours    
PEEP, cm H2O 6 (6-7) 7 (6-8) .008** 
?̅?aw, cm H2O 10 (9-11) 11 (10-12) .026* 
FiO2 .32 (.25-.40) .40 (.30-.55) .002** 
RSS 3.3 (2.5-4.5) 4.4 (2.9-6.3) .001** 
pH 7.31 (7.24-7.35) 7.22 (7.15-7.30) .003** 
PCO2, mm Hg 56.4 (49.2-64) 64 (50-69) .20 
12-hours     
PEEP, cm H2O 6 (6-7) 8 (6-9) .004** 
?̅?aw, cm H2O 10 (9-12) 12 (11-14) .004** 
FiO2 .35 (.25-.45) .50 (.38-.64) .004** 
RSS 3.4 (2.5-5.2) 5.6 (4.2-8.9) .004** 
pH 7.31 (7.26-7.36) 7.25 (7.18-7.35) .038* 
PCO2, mm Hg 56.9 (50.3-64.6) 55 (46-69.5) .90 
24-hours    
PEEP, cm H2O 6 (6-7) 8 (7-10) .004** 
?̅?aw, cm H2O 10 (9-12) 12 (11-14) .004** 
FiO2 .35 (.25-.41) .50 (.40-.60) .004** 
RSS 3.6 (2.7-5.2) 6.3 (4.5-8.2) .004** 
pH 7.34 (7.31-7.38) 7.28 (7.21-7.33) .004** 
PCO2, mm Hg 50.2 (46.1-58.1) 57.5 (48-65) .062 
Table 10. Results are presented as median (interquartile range). CMV = conventional mechanical ventilation, HFV = high-frequency ventilation, 
PEEP = positive end-expiratory pressure for conventional ventilation (left) and high-frequency jet ventilation (right), ?̅?aw = mean airway 
pressure for conventional ventilation (left) and high-frequency jet ventilation or high-frequency oscillatory ventilation (right), FiO2 = Fraction of 
Inspired Oxygen, RSS = Respiratory Severity Score, PCO2 = partial pressure of carbon dioxide via blood gas. *p <.05. **p <.01. 
 
